Share Issue/Capital Change • Jul 31, 2024
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
The number of shares and votes in BioGaia AB (publ) increased in July due to the exercise of some warrants issued under the BioGaia incentive program 2021/2024 for subscription of shares. Through this subscription, the number of Class B shares and votes in BioGaia increased by 35,000 and the share capital increased by SEK 7,000.
As of July 31, 2024, the total number of shares in BioGaia amounts to 101,017,310, of which 3,703,340 are Class A shares with ten votes each and 97,313,970 are Class B shares with one vote each, totaling 134,347,370 votes. Additionally, the share capital amounts to SEK 20,203,462.
As of July 31, 2024, BioGaia holds no treasury shares.
Follow us: Subscribe to BioGaia press releases here LinkedIn here
Contacts: Alexander Kotsinas, CFO Email: [email protected] Phone: +46 735 00 11 11
Mikaela Idermark Stern, Corporate Communications Email: [email protected] Phone: +46 730 95 61 50
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. bioqaiaqroup.com
This disclosure contains information that BioGaia is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 31-07-2024 at 11:00 CEST.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.